Bain-Capital-Life-Sciences-Investors

Filing Details

13F-HR2025-03-31
Report Date
2025-03-31
Filing Date
2025-05-15
Total Holdings
24
Total Value
675912941
Accession Number
0000950123-25-005465
Form Type
13F-HR
Manager Name
Bain-Capital-Life-Sciences-Investors
Data Enrichment
96% identified
23 identified1 unidentified

Holdings

24 positions
Manager:
Search and click to pin securities to the top
Page 1 of 2
NewAmsterdam Pharma Co N.V.
Shares:10.7M
Value:$219.4M
Nuvalent, Inc.
Shares:1.4M
Value:$102.6M
Pharvaris N.V.
Shares:3.3M
Value:$51.9M
Disc Medicine, Inc.
Shares:983.5K
Value:$48.8M
Dianthus Therapeutics, Inc. /DE/
Shares:2.7M
Value:$48.8M
Savara Inc
Shares:17.6M
Value:$48.8M
Solid Biosciences Inc.
Shares:7.9M
Value:$29.3M
Olema Pharmaceuticals, Inc.
Shares:6.8M
Value:$25.7M
RAPID MICRO BIOSYSTEMS, INC.
Shares:8.4M
Value:$22.3M
Cidara Therapeutics, Inc.
Shares:703.1K
Value:$15.1M
Upstream Bio, Inc.
Shares:2.3M
Value:$14.0M
Annexon, Inc.
Shares:5.2M
Value:$10.1M
Atea Pharmaceuticals, Inc.
Shares:2.5M
Value:$7.4M
Kyverna Therapeutics, Inc.
Shares:3.4M
Value:$6.5M
X4 Pharmaceuticals, Inc
Shares:16.9M
Value:$4.0M
Cabaletta Bio, Inc.
Shares:2.8M
Value:$3.8M
Tango Therapeutics, Inc.
Shares:2.7M
Value:$3.7M
Xilio Therapeutics, Inc.
Shares:4.6M
Value:$3.3M
Mersana Therapeutics, Inc.
Shares:8.7M
Value:$3.0M
Century Therapeutics, Inc.
Shares:5.4M
Value:$2.6M